Dyne Therapeutics (DYN) Preferred Shares (2019)

Dyne Therapeutics (DYN) posted quarterly Preferred Shares of $27.4 million for Q4 2019.

Dyne Therapeutics (DYN) Preferred Shares (2019) Analysis & Trends

Dyne Therapeutics (DYN) has reported Preferred Shares for 1 consecutive years, with $27.4 million the latest figure, recorded in Q4 2019.

In Q4 2019, Preferred Shares changed N/A year-over-year to $27.4 million; the TTM figure through Dec 2019 stood at $27.4 million (changed N/A YoY), while the FY2019 annual figure was $27.4 million, changed N/A from the prior year.
Preferred Shares was little changed at $27.4 million in Q4 2019 per DYN's latest filing.
Across five years, Preferred Shares topped out at $27.4 million in Q4 2019 and bottomed at $27.4 million in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Dyne Therapeutics	4.26 Bn	4.26 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	27.43 Mn